Literature DB >> 28249379

Clinical Usefulness of Fecal Microbiota Transplantation.

Jung Ho Park1.   

Abstract

Entities:  

Year:  2017        PMID: 28249379      PMCID: PMC5383109          DOI: 10.5056/jnm17024

Source DB:  PubMed          Journal:  J Neurogastroenterol Motil        ISSN: 2093-0879            Impact factor:   4.924


× No keyword cloud information.
Fecal microbiota transplantation (FMT) is the transfer of stool from healthy donors to patients with an altered colonic microbiome to cure a specific disease. The main goal of FMT is to restore the “normal” population of bacteria in a dysbiotic colonic environment. Until now, the strongest evidence for efficacy of FMT is the treatment of Clostridium difficile infection (CDI), especially for recurrent ones.1 The results showed that FMT was successful in 85% of recurrent CDI and 55% of refractory CDI compared with 30% to 80% success rates for medical therapies.2 Other possible applications for FMT may include diseases associated with dysbiosis such as inflammatory bowel disease, irritable bowel syndrome, Parkinson’s disease, and metabolic syndrome.3 In the current issue of Journal of Neurogastroenterology and Motility, Gu et al4 hypothesized that manipulating the gut microbiome through FMT could reverse intestinal dysbiosis and consequently resolve overt chronic intestinal pseudo-obstruction (CIPO). Nine patients with CIPO received FMT for 6 consecutive days through nasojejunal tubes and were followed up for 8 weeks after treatment. FMT significantly alleviated pain and bloating symptoms, but not vomiting and nausea. Enteral nutrition administered through a nasojejunal tube after FMT was well-tolerated by 66.7% (6/9) of patients. Computed tomography scores of intestinal obstructions were significantly reduced after FMT and small intestinal bacterial overgrowth (SIBO) was eliminated in 71% (5/7) of patients. Based on these findings, the author suggested that serial FMT may be a candidate therapy for CIPO. However, there are a few things to consider. We cannot agree with the hypothesis that if intestinal dysbiosis is reversed, then CIPO might be resolved. As mentioned in the introduction, the etiology of symptoms in CIPO is multifactorial, and dysbiosis is the result of CIPO, not the cause. Also, this study had several limitations, as the author said: small number of cases, no control group, short follow up period, and more than anything else, heterogeneity of participants. Of the 9 patients who participated in this study, 6 underwent surgical treatment, including ileostomy in 4 patients. These surgical procedures could have a great effect on the colonic bacteria. Nonetheless, it is interesting to note that resolving SIBO with FMT could improve the patient’s nutritional status of CIPO and FMT may be a good treatment option for patients with symptoms that are associated with SIBO.
  4 in total

Review 1.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

Authors:  Ethan Gough; Henna Shaikh; Amee R Manges
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

Review 2.  Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.

Authors:  Dimitri Drekonja; Jon Reich; Selome Gezahegn; Nancy Greer; Aasma Shaukat; Roderick MacDonald; Indy Rutks; Timothy J Wilt
Journal:  Ann Intern Med       Date:  2015-05-05       Impact factor: 25.391

Review 3.  Fecal Microbiota Transplantation.

Authors:  Stephen M Vindigni; Christina M Surawicz
Journal:  Gastroenterol Clin North Am       Date:  2017-03       Impact factor: 3.806

4.  Serial Frozen Fecal Microbiota Transplantation in the Treatment of Chronic Intestinal Pseudo-obstruction: A Preliminary Study.

Authors:  Lili Gu; Chao Ding; Hongliang Tian; Bo Yang; Xuelei Zhang; Yue Hua; Yifan Zhu; Jianfeng Gong; Weiming Zhu; Jieshou Li; Ning Li
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.